Core Viewpoint - The cooperation between Huaren Pharmaceutical and the Feidong People's Government marks a significant step in the company's integrated strategy of "raw materials + formulations + packaging" and aims to boost the local biopharmaceutical industry while achieving mutual benefits for both the company and the local economy [1][2] Group 1: Project Overview - Huaren Pharmaceutical signed a cooperation framework agreement for a raw material production base project on December 10, 2025, located in the Hefei Circular Economy Demonstration Park, covering an area of approximately 100 acres [1] - The project will adhere to GMP standards and focus on the research and production of high-value-added raw materials in fields such as respiratory and narcotic medicine [1] Group 2: Strategic Importance - The construction of the Feidong raw material production base is a key component of Huaren Pharmaceutical's full industry chain layout, enhancing the company's competitive edge through integrated cost control and supply chain management [2] - The establishment of the base will improve the company's ability to control the entire process from upstream raw material development to downstream formulation processing, thereby increasing market competitiveness [2] Group 3: Economic Impact - The raw material production base is expected to inject new vitality into the industrial upgrade and economic growth of Feidong County, contributing to the development of a distinctive and advantageous biopharmaceutical industry cluster [2] - The project will promote the optimization of regional economic structure and elevate industrial capabilities, aligning with the characteristics of the biopharmaceutical industry as a strategic emerging sector with high added value and growth potential [2] Group 4: Future Outlook - The company plans to deepen its integrated strategic layout, using the Feidong raw material production base as a pivot to enhance research and innovation capabilities while ensuring the stability of the pharmaceutical supply chain [2] - This collaboration is seen as a significant step in the company's strategic implementation and a model for the deep integration of the pharmaceutical industry with local economies [2]